Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN TUMOR NECROSIS FACTOR ALPHA, AND USE THEREOF
No-Receipt date
2010-00953 - 19/03/2010
No-Filing date
20100800011 - 19/03/2010
No-Granting date
8000339 - 05/10/2010
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
8/2010 - 24/09/2010
Gazette No-Publication date of granted patent
10/2010 - 18/11/2010
Expiration date
07/10/2024
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
NOT VALID
Priorities
-
Active Substance of Supplementary Certificates
CIMZIA με δραστική ουσία CERTOLIZUMAB PEGOL
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20100400561
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
308522
UCB PHARMA, S.A.
ALLEE DE LA RECHERCHE 60
1070 BRUSSELS
BELGIUM
Inventors
Code
Firstname
Surname
726389
ATHWAL, DILJEET SINGH
726390
BROWN, DEREK THOMAS
726391
WEIR, ANDREW NEIL CHARLES
726392
POPPLEWELL, ANDREW GEORGE
726393
CHAPMAN, ANDREW PAUL
726394
KING, DAVID JOHN
Representatives
Code
Firstname
Surname
Address
Town
Zip
956
NIKOLAOS
LYMPERIS
STOURNARA 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2832
NIKOLAOS
LYMPERIS
STOURNARA 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
11/4/2024 12:00:00 AM
Λήξη Προστασίας Τίτλων (79600)
79600
Payments history
4 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).